To help clinicians avoid remedies that may potentially contribute to a patient’s death, researchers at MIT and elsewhere have developed a machine-learning model that could be used to identify treatments that pose a higher risk than other options.
Sometimes, software is just like us. It can be bloated, slow, and messy. Humans might see a doctor if these symptoms persist (maybe not for messiness), but rarely do we push a flawed software program to go see its developer time and time again.